Dr. Vinnedge tests novel breast cancer therapeutics and works to identify biomarkers of disease and disease progression from patient samples.

Kaitlyn Gardner has a BA in neuroscience from DePauw University. She began working at Cincinnati Children’s Hospital in 2021 and joined the Privette Vinnedge lab in 2023. She uses structure function assays to look at the oncogenic functions of mutant strains of Dek and will also use iPSCs and mouse models to study the role of DEK in neuronal function.

Faith Lanzillo is an undergraduate student at Xavier University pursuing a degree in biology. She joined the lab as a student laboratory assistant in the summer of 2023. She supports the lab’s goal of understanding the molecular drivers of cancer and provides technical assistance for procedures that help further this goal.

Ashley has a BS in biological studies from the University of Cincinnati. She starting working at Cincinnati Children’s Hospital in 2016 and joined the Privette Vinnedge lab in 2022. She uses cell culture and mouse models to understand the molecular mechanism that drive DEK-induced proliferation in mammary epithelial cells.

Sophia Schutte is an undergraduate student at Xavier University pursuing a degree in biomedical sciences. She joined the lab for the Summer Undergraduate Research Fellowship (SURF) in the summer of 2022. She continues to support the lab during the academic year providing technical assistance to understand the molecular mechanism that drive DEK-induced proliferation in mammary epithelial cells and the oncogenic mechanisms of DEK over-expression.